Extended Data Table 1 MSK derivation cohort cluster characteristics

From: An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

  1. 1Wilcoxon rank-sum test; Pearson’s Chi-squared test; Fisher’s exact test. All tests were 2-sided with a significance level of 0.05. Bridging therapy: antineoplastic therapy administered between apheresis and lymphodepleting chemotherapy prior to CAR-T infusion.
  2. IQR, interquartile range.
Back to article page